Doctors and Patients View Inhaler Devices as Less Important than COPD Medication, Survey Shows

Doctors and Patients View Inhaler Devices as Less Important than COPD Medication, Survey Shows

A recently published survey showed that both patients and healthcare providers place less importance on inhaler devices than medication in the treatment of chronic obstructive pulmonary disease (COPD).

Even though past studies have shown that learning good inhaler techniques is key to achieving optimal COPD care, the survey revealed that both patients and healthcare providers were relatively unconcerned with their proper use.

The survey was conducted as part of an ongoing project — Delivery Makes a Difference (DMaD) — to better understand the perspectives of healthcare providers and patients about the role of inhalation delivery devices in COPD. According to a press release, the team believes that the generalized poor understanding and misuse of inhaler devices might be the main reasons for ineffective COPD management.

Researchers from the American College of Chest Physicians conducted the survey and their findings were published in the Journal of the COPD Foundation under the title “The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.”

Researchers analyzed data derived from two web-based surveys of 513 healthcare providers managing COPD and 499 patients with COPD across the United States.

Results from the survey revealed that the type of inhaler device was only of limited importance to physicians when prescribing medication for newly diagnosed patients — only 37 percent of physicians said the choice of the device was highly important, and only 45 percent said they evaluated the patient’s technique when first prescribing a device.

Furthermore, even though most physicians said they gave individualized one-on-one training, most did not report consistently checking device technique in newly diagnosed patients. Such assessment occurred even less often among primary care providers compared to pulmonologists (32 versus 52 percent).

In addition, when treating COPD patients with frequent exacerbations, 87 percent of healthcare providers said they were much more likely to change or add medications than to switch to a different inhaler while maintaining the same medication. These changes in treatment were also typically triggered by disease symptoms and exacerbations, rather than by poor device technique.

According to the team, only two factors were associated with a higher probability of changing devices to one that was easier to use: low-medication adherence and patient management by a pulmonologist.

Concerning patients, the survey showed that most (64 percent) were relatively unconcerned about proper device use, regardless of their COPD severity.

Also, barriers to optimal inhaler use were found to be relatively common among COPD patients. Those with the lowest adherence scores were more likely to report physical difficulties when handling their medication or devices, including arthritis, difficult fine motor movement, or poor eyesight.

In fact, a recent study showed that patients with COPD and rheumatoid arthritis struggle to manage their respiratory condition because their inhalers are too complex given their physical limitations.

Researchers believe that improved educational efforts could help ensure proper selection and use of inhalation devices, ultimately leading to better clinical outcomes and reduced costs. Such education efforts should also address healthcare professionals’ time constraints, which have also been mentioned as a barrier to provide effective patient education on inhaler use, they added.

Print Friendly, PDF & Email


  1. Sharon J Benum says:

    The inhaler is the only thing to take. The medication can give you lung infections which can put you in the hospital and probably does a good job of damaging the lungs even more. Why anyone would even take any of these meds unless their COPD is worse than the side effects of the meds, is beyond me. I’m stage 3 and I use only the inhaler. I don’t need the glaucoma or lung infections that the meds can make you prone to. I have enough problems with the emphysema.

  2. maurice chikiar says:

    I am mystified that MDI’s are shown without a spacer or holding chamber. I’m a respiratory therapist working under the impression that research has shown that when a spacer or holding chamber are used with an MDI, the patient gets more medicine delivered to the lungs. Therefore it would seem reasonable that MDI’s be paired with a spacer whenever they are pictured. I think this would also encourage the use of spacers or holding chambers.

Leave a Comment

Your email address will not be published. Required fields are marked *